<main class="html-publication" role="main" lang="en">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          <div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">
      <span class="gem-c-organisation-logo__name">Medicines &amp; Healthcare products<br>Regulatory Agency</span>
</a>
</div>

        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  <div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
    <span class="govuk-caption-xl gem-c-title__context">
      Notice
    </span>
  <h1 class="gem-c-title__text ">
    Notice concerning regulation 251
  </h1>
</div>
  <p class="publication-header__last-changed">Published 30 March 2021</p>

  </header>




<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-e98134ae65ff5fe99a524d8c383350b3998f91c298dc24b36126e65f1656c578.png">
</p>
<p>
  © Crown copyright 2021
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/regulation-251-of-the-human-medicines-regulations-2020/notice-concerning-regulation-251
</p>


    </div>
  </div>

  <div class="main-content-container offset-empty-contents-list">
    <div class="gem-c-govspeak-html-publication">
  
<div data-module="govspeak" class="gem-c-govspeak govuk-govspeak ">
    
    
      <div class="govspeak">
<p>The UK remains a member of Council of Europe and the European Pharmacopoeia following the Brexit transition.</p>

<p>The <a href="https://www.pharmacopoeia.com/" rel="external" class="govuk-link">British Pharmacopoeia (BP)</a> continues to reproduce <a rel="external" href="https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition" class="govuk-link">European Pharmacopoeia (Ph. Eur.)</a> text for the convenience of our customers.</p>

<p>The UK was a founding member of the ‘Convention on the Elaboration of a European Pharmacopoeia’ and continues to be a member of the Ph. Eur. as the UK continues to be a member of the Council of Europe in its own right.</p>

<p>The UK remains an active member of the European Pharmacopoeia Commission through the BP.</p>

<p>Compliance with the BP continues to be a mandatory requirement in the UK, including Northern Ireland. Products in the UK are expected to meet the standards published by the BP.</p>

<p>This requirement remains the same after the transition period in accordance with the <a rel="external" href="https://www.legislation.gov.uk/uksi/2020/1488/pdfs/uksiem_20201488_en.pdf" class="govuk-link">Human Medicines Regulations (Regulation 251)</a>.</p>

<p>In exceptional circumstances, an EU derived marketing authorisation for a product that enters Northern Ireland via the Northern Ireland Protocol, and the UK via <a class="govuk-link" href="https://www.gov.uk/guidance/unfettered-access-procedure-for-marketing-authorisations-approved-in-northern-ireland">unfettered access</a>, may not comply with the standard specified in the relevant BP monograph.</p>

<p>The Human Medicine Regulations have been amended to include a temporary exception to ensure these products can remain on the market whilst the relevant monograph is revised, if appropriate. If a revised monograph is published the exception is no longer applicable.</p>
</div>


</div>
</div>
  </div>

  <div data-sticky-element="" class="sticky-element">
    <a href="#contents" class="govuk-link app-c-back-to-top dont-print">
    <svg focusable="false" class="app-c-back-to-top__icon" width="13" viewBox="0 0 13 17" xmlns="http://www.w3.org/2000/svg" height="17">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button data-module="print-link" class="govuk-link gem-c-print-link__button">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>